☆ 4.8 Article

Therapeutic neutralizing monoclonal antibody administration protects against lethal yellow fever virus infection

SCIENCE TRANSLATIONAL MEDICINE (2023)

Related references

Note: Only part of the references are listed.

Article Immunology

Viral Kinetics in Sylvatic Yellow Fever Cases

Vivian Avelino-Silva et al.

Summary: This study found an independent association between yellow fever virus viral load and mortality, highlighting the importance of monitoring viremia. Early use of antiviral drugs or neutralizing monoclonal antibodies may improve disease outcomes.

JOURNAL OF INFECTIOUS DISEASES (2023)

Add to Collection

Article Microbiology

Biological Characterization of Yellow Fever Viruses Isolated From Non-human Primates in Brazil With Distinct Genomic Landscapes

Nathalia Dias Furtado et al.

Summary: This study found differences in infectivity and neurovirulence of yellow fever virus isolates from different regions in mammalian and mosquito cells, suggesting the presence of genomic markers that increase host infectivity in certain strains.

FRONTIERS IN MICROBIOLOGY (2022)

Add to Collection

Article Microbiology

Isolation of a Potently Neutralizing and Protective Human Monoclonal Antibody Targeting Yellow Fever Virus

Michael P. Doyle et al.

Summary: Yellow fever virus (YFV) is a mosquito-borne virus that occasionally causes outbreaks of severe infection in South America and sub-Saharan Africa. Effective vaccines have been developed, but recent production and distribution issues have left many people vulnerable. This study aimed to isolate an antibody from individuals who had received the YFV vaccine for future use as a biologic drug. The most powerful antiviral antibody was found to be effective in animal models of human infection. These studies provide insights into the human immune response to YFV and offer a potential therapeutic antibody candidate for inhibiting highly virulent strains of the virus.

MBIO (2022)

Add to Collection

Article Cell Biology

LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants

Kathryn Westendorf et al.

Summary: A monoclonal antibody named LY-CoV1404 has been successfully isolated, which demonstrates highly potent neutralization against multiple variants of the SARS-CoV-2 virus. The binding site of LY-CoV1404 remains relatively conserved, allowing it to maintain its activity. This finding suggests that LY-CoV1404 has the potential to be an effective therapeutic agent against all known variants.

CELL REPORTS (2022)

Add to Collection

Article Multidisciplinary Sciences

A neutralizing-protective supersite of human monoclonal antibodies for fever virus

Yan Li et al.

Summary: Researchers have isolated eight human monoclonal antibodies that can neutralize yellow fever virus (YFV) infection, with two of them showing ultra-potent neutralizing activity and providing complete protection against YFV in a mouse model. Crystal structure analysis revealed the mechanisms by which these antibodies inhibit viral infection, and identified a vulnerable supersite that could be targeted for vaccine design.

INNOVATION (2022)

Add to Collection

Review Immunology

Immunotherapeutic strategies to target vulnerabilities in the Ebolavirus glycoprotein

John Misasi et al.

Summary: The article reviews the treatment methods of Ebola virus outbreak, including two therapies approved by the FDA using monoclonal antibodies. It introduces a new method to define vulnerable sites on the viral glycoprotein, hoping to combat Ebola virus and other emerging viruses.

IMMUNITY (2021)

Add to Collection

Article Biology

The global burden of yellow fever

Katy A. M. Gaythorpe et al.

Summary: This study analyzed the transmission of yellow fever in Africa and South America using mathematical modeling, and evaluated the impact of vaccination activities on mortality rates. The results showed that mass vaccination activities effectively reduced mortality rates in Africa, highlighting the importance of continued vigilance and surveillance of yellow fever.

ELIFE (2021)

Add to Collection

Article Multidisciplinary Sciences

Longitudinal dynamics of the human B cell response to the yellow fever 17D vaccine

Anna Z. Wec et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

Add to Collection

Article Multidisciplinary Sciences

Cross-neutralization ofSARS-CoV-2 by a human monoclonal SARS-CoV antibody

Dora Pinto et al.

NATURE (2020)

Add to Collection

Review Immunology

Review of data and knowledge gaps regarding yellow fever vaccine-induced immunity and duration of protection

J. Erin Staples et al.

NPJ VACCINES (2020)

Add to Collection

Article Medicine, General & Internal

Phase 1 Trial of a Therapeutic Anti-Yellow Fever Virus Human Antibody

Jenny G. Low et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection

Editorial Material Gastroenterology & Hepatology

Liver Transplantation for Fulminant Hepatitis Attributed to Yellow Fever

Alice Tung Wan Song et al.

HEPATOLOGY (2019)

Add to Collection

Article Cell Biology

Yellow fever and orthotopic liver transplantation: new insights from the autopsy room for an old but re-emerging disease

Amaro N. Duarte-Neto et al.

HISTOPATHOLOGY (2019)

Add to Collection

Article Infectious Diseases

Predictors of mortality in patients with yellow fever: an observational cohort study

Esper G. Kallas et al.

LANCET INFECTIOUS DISEASES (2019)

Add to Collection

Article Medicine, General & Internal

A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics

Sabue Mulangu et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Add to Collection

Article Cell Biology

Double Lock of a Human Neutralizing and Protective Monoclonal Antibody Targeting the Yellow Fever Virus Envelope

Xishan Lu et al.

CELL REPORTS (2019)

Add to Collection

Review Immunology

Passive immunotherapy of viral infections: 'super-antibodies' enter the fray

Laura M. Walker et al.

NATURE REVIEWS IMMUNOLOGY (2018)

Add to Collection

Article Parasitology

Genome analysis of yellow fever virus of the ongoing outbreak in Brazil reveals polymorphisms

Myrna C. Bonaldo et al.

MEMORIAS DO INSTITUTO OSWALDO CRUZ (2017)

Add to Collection

Article Biotechnology & Applied Microbiology

Dengue Virus Evades AAV-Mediated Neutralizing Antibody Prophylaxis in Rhesus Monkeys

Diogo M. Magnani et al.

MOLECULAR THERAPY (2017)

Add to Collection

Article Infectious Diseases

Ontogeny of the B- and T-cell response in a primary Zika virus infection of a dengue-naive individual during the 2016 outbreak in Miami, FL

Michael J. Ricciardi et al.

PLOS NEGLECTED TROPICAL DISEASES (2017)

Add to Collection

Review Immunology

Questions regarding the safety and duration of immunity following live yellow fever vaccination

Ian J. Amanna et al.

EXPERT REVIEW OF VACCINES (2016)

Add to Collection

Article Multidisciplinary Sciences

Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody

Davide Corti et al.

SCIENCE (2016)

Add to Collection

News Item Medicine, General & Internal

First US case of Zika virus infection is identified in Texas

Michael McCarthy

BMJ-BRITISH MEDICAL JOURNAL (2016)

Add to Collection

News Item Medicine, General & Internal

First US case of Zika virus infection is identified in Texas

Michael McCarthy

BMJ-BRITISH MEDICAL JOURNAL (2016)

Add to Collection

Article Public, Environmental & Occupational Health

Local Mosquito-Borne Transmission of Zika Virus — Miami-Dade and Broward Counties, Florida, June–August 2016

Anna Likos et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2016)

Add to Collection

Editorial Material Biotechnology & Applied Microbiology

Serious adverse events associated with yellow fever vaccine

Reinaldo de Menezes Martins et al.

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2015)

Add to Collection

Article Multidisciplinary Sciences

Future Economics of Liver Transplantation: A 20-Year Cost Modeling Forecast and the Prospect of Bioengineering Autologous Liver Grafts

Dany Habka et al.

PLOS ONE (2015)

Add to Collection

Article Pharmacology & Pharmacy

Humanized monoclonal antibody 2C9-cIgG has enhanced efficacy for yellow fever prophylaxis and therapy in an immunocompetent animal model

Justin G. Julander et al.

ANTIVIRAL RESEARCH (2014)

Add to Collection

Article Infectious Diseases

Pathophysiologic and Transcriptomic Analyses of Viscerotropic Yellow Fever in a Rhesus Macaque Model

Flora Engelmann et al.

PLOS NEGLECTED TROPICAL DISEASES (2014)

Add to Collection

Review Virology

Immunity and immune response, pathology and pathologic changes: progress and challenges in the immunopathology of yellow fever

Juarez A. S. Quaresma et al.

REVIEWS IN MEDICAL VIROLOGY (2013)

Add to Collection

Article Pharmacology & Pharmacy

A humanized IgG but not IgM antibody is effective in prophylaxis and therapy of yellow fever infection in an AG129/17D-204 peripheral challenge mouse model

Brett A. Thibodeaux et al.

ANTIVIRAL RESEARCH (2012)

Add to Collection

Article Virology

Structure and Function Analysis of Therapeutic Monoclonal Antibodies against Dengue Virus Type 2

Soila Sukupolvi-Petty et al.

JOURNAL OF VIROLOGY (2010)

Add to Collection

Article Virology

Antibody responses against wild-type yellow fever virus and the 17D vaccine strain: Characterization with human monoclonal antibody fragments and neutralization escape variants

S Daffis et al.

VIROLOGY (2005)

Add to Collection

© Peeref 2019-2024. All rights reserved.